Skip to main content
BrainCited

Figure 2

Diagram
888 × 620px · 310.7 केबी 

Source Paper

Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.

Molecules (Basel, Switzerland) (2024)

PMID: 39274904

DOI: 10.3390/molecules29174056

Cite This Figure

![Figure 2: Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.](https://pdfs.citedhealth.com/figures/39274904/156.png)

> Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." *Molecules (Basel, Switzerland)*, 2024. PMID: [39274904](https://pubmed.ncbi.nlm.nih.gov/39274904/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39274904/156.png" alt="Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics." />
  <figcaption>Figure 2. Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.<br>  Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." <em>Molecules (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39274904/">39274904</a></figcaption>
</figure>